<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Reduced vascular risk factors in Parkinson&apos;s disease dementia and dementia with Lewy bodies compared to Alzheimer&apos;s disease</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Po-Chi</forename><surname>Chan</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Show Chwan Memorial Hospital</orgName>
								<address>
									<settlement>Changhua</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">| Cheng-Yu</forename><surname>Wei</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Chang Bing Show Chwan Memorial Hospital</orgName>
								<address>
									<settlement>Changhua</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Guang-Uei</forename><surname>Hung</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Nuclear Medicine</orgName>
								<orgName type="institution">Chang Bing Show Chwan Memorial Hospital</orgName>
								<address>
									<settlement>Changhua</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">|</forename><surname>Pai</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Yi</forename><surname>Chiu</surname></persName>
							<idno type="ORCID">0000-0003-2552-4516</idno>
							<affiliation key="aff0">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Show Chwan Memorial Hospital</orgName>
								<address>
									<settlement>Changhua</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Chang Bing Show Chwan Memorial Hospital</orgName>
								<address>
									<settlement>Changhua</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Pai-Yi</forename><surname>Chiu</surname></persName>
						</author>
						<author>
							<persName><forename type="first">P-C</forename><surname>Chan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">G-U</forename><surname>Chiu</surname></persName>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Show Chwan Memorial Hospital</orgName>
								<address>
									<settlement>Changhua</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Reduced vascular risk factors in Parkinson&apos;s disease dementia and dementia with Lewy bodies compared to Alzheimer&apos;s disease</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">74063F9E26A5AE3876A15888CA9862E0</idno>
					<idno type="DOI">10.1002/brb3.916</idno>
					<note type="submission">Received: 13 May 2017 | Revised: 14 December 2017 | Accepted: 21 December 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:37+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Alzheimer&apos;s disease</term>
					<term>dementia with Lewy bodies</term>
					<term>Lewy body dementia</term>
					<term>Parkinson&apos;s disease dementia</term>
					<term>vascular risk factors</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Growing evidence has supported the influence of vascular risk factors (VRFs) on incidence of dementia due to Alzheimer's disease (AD) as well as of vascular dementia (VaD) <ref type="bibr" target="#b2">(Biessels &amp; Kappelle, 2005;</ref></s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>increased risk of all dementia, a 56% increase in AD, and an 127% increase in VaD <ref type="bibr" target="#b12">(Gudala et al., 2013)</ref>.</s><s>Midlife VRFs including hypertension, hypercholesterol, obesity, and diabetes are most contributing to late-life incident dementia due to AD <ref type="bibr" target="#b2">(Biessels &amp; Kappelle, 2005;</ref><ref type="bibr" target="#b8">Fitzpatrick et al., 2009;</ref><ref type="bibr" target="#b16">Kivipelto et al., 2005;</ref><ref type="bibr" target="#b18">Luchsinger et al., 2005;</ref><ref type="bibr" target="#b26">Reitz et al., 2010)</ref>.</s><s>Besides, most of the VRFs including hypertension, diabetes, heart disease, dyslipidemia, and smoking are contributing to the incident dementia associated with stroke <ref type="bibr" target="#b10">(Forette et al., 2002;</ref><ref type="bibr" target="#b11">Gorelick, 2004;</ref><ref type="bibr" target="#b17">Launer et al., 2000;</ref><ref type="bibr" target="#b19">Luchsinger et al., 2001)</ref>.</s><s>However, studies on the association between VRFs and Lewy body dementia (LBD) are limited.</s><s>Previous studies had put more emphasis on the association of VRFs mainly with Parkinson's disease (PD) patients regardless of whether or not they developed dementia, and the results were controversial <ref type="bibr" target="#b13">(Haugarvoll, Aarsland, Wentzel-Larsen, &amp; Larsen, 2005;</ref><ref type="bibr" target="#b25">Papapetropoulos, Villar, &amp; Mash, 2006;</ref><ref type="bibr" target="#b24">Papapetropoulos et al., 2004;</ref><ref type="bibr" target="#b27">Rektor et al., 2009;</ref><ref type="bibr" target="#b28">Schelp, Mendes-Chiloff, Bazan, Paduan, &amp; Pioltini, 2012;</ref><ref type="bibr" target="#b29">Scigliano et al., 2006;</ref><ref type="bibr" target="#b30">Simon, Chen, Schwarzschild, &amp; Ascherio, 2007;</ref><ref type="bibr" target="#b32">Sławek et al., 2008</ref><ref type="bibr" target="#b33">Sławek et al., , 2010;;</ref><ref type="bibr" target="#b35">Toledo et al., 2013)</ref>.</s></p><p><s>Reduced risk factors for vascular disorders were found in patients with PD <ref type="bibr" target="#b29">(Scigliano et al., 2006)</ref> or with α-synucleinopathy <ref type="bibr" target="#b35">(Toledo et al., 2013)</ref>.</s><s>Some studies suggested that PD risk was not significantly related to history of hypertension, hypercholesterolemia, or diabetes <ref type="bibr" target="#b13">(Haugarvoll et al., 2005;</ref><ref type="bibr" target="#b28">Schelp et al., 2012;</ref><ref type="bibr" target="#b30">Simon et al., 2007;</ref><ref type="bibr" target="#b32">Sławek et al., 2008</ref><ref type="bibr" target="#b33">Sławek et al., , 2010))</ref>, and other studies showed positive contribution <ref type="bibr" target="#b24">(Papapetropoulos et al., 2004</ref><ref type="bibr" target="#b25">(Papapetropoulos et al., , 2006;;</ref><ref type="bibr" target="#b27">Rektor et al., 2009)</ref>.</s><s>Although dementia with Lewy bodies (DLB) is the second most common degenerative dementia <ref type="bibr" target="#b15">(Karantzoulis &amp; Galvin, 2013;</ref><ref type="bibr" target="#b21">McKeith et al., 1996)</ref>, the study of VRFs associated with DLB is scarce <ref type="bibr" target="#b3">(Boot et al., 2013)</ref>.</s><s>On account of findings on the association of VRFs in Parkinson's disease dementia (PDD) and DLB are still limited, we aim to study and compare the prevalence of various VRFs of DLB and PDD with AD.</s><s>We propose that DLB and PDD will present with very approximate patterns of association of VRFs because of their similar clinical and pathological manifestation, but association patterns between DLB/PDD and AD will be different.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2">| METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1">| Participants</head><p><s>This study is part of a dementia project in central Taiwan <ref type="bibr" target="#b4">(Chiu, Tsai, Chen, Liu, &amp; Lai, 2015)</ref>.</s><s>A consecutive series of patients visited the dementia clinic fulfill the criteria for AD, DLB, or PDD were enrolled, and their demographic and clinical data including VRFs were analyzed in this study.</s><s>The dementia patients were diagnosed according to the criteria for primary degenerative dementia in the fourth edition of the Diagnostic and Statistic Manual of Mental Disorders (DSM-IV).</s><s>The DLB patients were diagnosed according to the revised consensus criteria for probable or possible DLB developed by the third report of the DLB consortium <ref type="bibr" target="#b20">(McKeith et al., 2005)</ref>.</s><s>The PDD patients were diagnosed according to the clinical criteria for possible or probable PDD developed by the Movement Disorder Society (MDS) in 2007 <ref type="bibr" target="#b6">(Emre et al., 2007)</ref>.</s><s>The patients with AD were diagnosed according to the criteria for probable or possible AD developed by the National Institute of Neurologic and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) <ref type="bibr" target="#b22">(McKhann et al., 1984)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2">| Assessment tools</head><p><s>The following variables in all participants were analyzed: smoking, diabetes, hypertension, cerebrovascular disease, cardiovascular disease, and blood pressure, sugar, cholesterol, triglycerides, and total lipids.</s><s>Smoking, diabetes, hypertension, cerebrovascular, and cardiovascular diseases were analyzed as dichotomous variables with no history or not present as reference categories.</s><s>Blood pressure, blood sugar, cholesterol, triglycerides, and total lipids were categorized into tertiles based on their distribution in controls, with lowest tertile as reference.</s><s>Patients with diabetes or hypertension were assigned to the third tertile of blood sugar or blood pressure (systolic and diastolic), respectively.</s></p><p><s>The global severity of dementia is assessed according to the Clinical Dementia Rating (CDR) scale and sum of boxes of CDR (CDR-SB) <ref type="bibr" target="#b23">(Morris, 1993)</ref>.</s><s>Cognitive functions were assessed with the Mini-mental State Examination (MMSE) <ref type="bibr" target="#b9">(Folstein, Folstein, &amp; McHugh, 1975)</ref> and the Cognitive Abilities Screening Instrument (CASI) <ref type="bibr" target="#b34">(Teng et al., 1994)</ref>.</s><s>Motor functions were assessed with motor score of the Unified Parkinson's Disease Rating Scale (UPDRS-m) <ref type="bibr" target="#b1">(Ballard et al., 1997)</ref>.</s><s>Fluctuation was diagnosed when a clinical history of fluctuation in cognition and a Mayo Fluctuations Composite Score (MFCS) &gt; 2 were both present <ref type="bibr" target="#b7">(Ferman et al., 2004)</ref>.</s><s>Visual hallucinations (VHs) were diagnosed when a clinical history of recurrent VHs and a hallucination subscale in NPI (NPH-H) &gt; 0 were both present <ref type="bibr" target="#b5">(Cummings et al., 1994)</ref>.</s><s>Parkinsonism was diagnosed when at least 2 of the following were present: bradykinesia, tremor, rigidity, and postural insta-</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3">| Data analysis</head><p><s>The</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4">| Ethical consideration</head><p><s>The Committee for Medical Research Ethics of Show Chwan Hospital reviewed the project, and the Data Inspectorate approved it.</s><s>All participants signed the informed consent when they agreed to join the study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3">| RESULTS</head><p><s>A total of 167 patients with complete data were analyzed.</s><s>Among them, 55 had DLB, 34 had PDD, and 78 had AD.</s><s>Table <ref type="table">1</ref> summarizes the demographic characteristic of all patients.</s><s>DLB group had significant higher CDR-SB (F = 4.045, p = .018)</s><s>than AD.</s><s>Both DLB and PDD groups had higher UPDRS motor score than AD.</s><s>Sex, age, onset age, education, CDR, MMSE, and CASI were not different between three groups of patients (p = NS).</s><s>Comparisons of clinical features showed higher frequencies of fluctuation, visual hallucinations (VHs), parkinsonism, and RBD for DLB group than AD group (all p .05).</s><s>PDD group had significantly higher frequencies of fluctuation, parkinsonism, VHs, and RBD than the AD group (all p &lt; .05).</s></p><p><s>The comparisons of the clinical history and medication are summarized in Table <ref type="table">2</ref>.</s><s>The results showed that history of hypertension and diabetes was lower in PDD than AD [odds ratio (OR) = 0.38].</s></p><p><s>Atherosclerosis was lower in DLB than AD (OR = 0.26).</s></p><p><s>The measurements of VRFs are summarized in Table <ref type="table">3 and</ref>   T A B L E 1 Demographic and background characteristics of DLB, PDD, and AD patients</s></p><p><s>The main finding of this study was that the VRFs associated with DLB and PDD were similar but were distinct from those with AD.</s><s>By comparing the clinical history of VRFs among three groups, there is no different association among DLB, PDD, and AD.</s><s>This finding was partially consistent with the results of two recent studies regarding the risk factors for Lewy body disease <ref type="bibr" target="#b3">(Boot et al., 2013;</ref><ref type="bibr" target="#b33">Sławek et al., 2010)</ref>.</s><s>However, the measurements of these factors in our study further demonstrated a different association pattern of VRFs between DLB/PDD and AD.</s><s>DLB and PDD presented similar pattern and showed lower association with some of the factors compared to AD.</s><s>This finding is consistent with two previous studies <ref type="bibr" target="#b29">(Scigliano et al., 2006;</ref><ref type="bibr" target="#b33">Sławek et al., 2010;</ref><ref type="bibr" target="#b35">Toledo et al., 2013)</ref>.</s><s>Results from a large case-control study showed reduced risk factors for vascular disorders were found in patients with PD <ref type="bibr" target="#b29">(Scigliano et al., 2006)</ref>.</s><s>A large-scale study of the contribution of cerebrovascular disease in autopsy-confirmed neurodegenerative disease cases revealed that the prevalence of vascular pathology and cerebrovascular disease was reduced in patients with α-synucleinopathy compared to those with Alzheimer's disease (AD) <ref type="bibr" target="#b35">(Toledo et al., 2013)</ref>.</s><s>Among the few researches regarding VRFs as well as metabolic syndrome (MetS), association with Lewy body disease revealed that reduced VRFs were noted in patients with PD <ref type="bibr" target="#b33">(Sławek et al., 2010)</ref>.</s><s>Results of this study also revealed a modest decline of the risk with increasing blood cholesterol levels <ref type="bibr" target="#b33">(Sławek et al., 2010)</ref>.</s></p><p><s>Whether or not systemic or brain vascular diseases contribute to the progression of PD patients to the development of cognitive dysfunction or dementia is still controversial.</s><s>Some studies of the association of VRFs with PD revealed no significantly contribution of VRFs to the risk of PD or to the progression of PD to PDD <ref type="bibr" target="#b13">(Haugarvoll et al., 2005;</ref><ref type="bibr" target="#b28">Schelp et al., 2012;</ref><ref type="bibr" target="#b30">Simon et al., 2007;</ref><ref type="bibr" target="#b32">Sławek et al., 2008</ref><ref type="bibr" target="#b33">Sławek et al., , 2010))</ref>.</s></p><p><s>The others provided positive conclusion <ref type="bibr" target="#b24">(Papapetropoulos et al., 2004</ref><ref type="bibr" target="#b25">(Papapetropoulos et al., , 2006;;</ref><ref type="bibr" target="#b27">Rektor et al., 2009)</ref>   <ref type="bibr">et al., 2004)</ref> and dementia <ref type="bibr" target="#b25">(Papapetropoulos et al., 2006)</ref>.</s></p><p><s>Leaving aside the controversy of contribution of brain or systemic vascular disorders to parkinsonism or dementia, well control of each VRF is important for the prevention of cardiovascular disorders.</s><s>In older patients and those with significant comorbid illnesses, target of control of each VRF is probably different from that of younger or healthy adults <ref type="bibr" target="#b14">(Huang &amp; Davis, 2015)</ref>.</s><s>Although midlife VRFs are most contributing to late-life incident dementia due to AD or other dementia <ref type="bibr" target="#b2">(Biessels &amp; Kappelle, 2005;</ref><ref type="bibr" target="#b8">Fitzpatrick et al., 2009;</ref><ref type="bibr" target="#b16">Kivipelto et al., 2005;</ref><ref type="bibr" target="#b18">Luchsinger et al., 2005;</ref><ref type="bibr" target="#b26">Reitz et al., 2010)</ref>, the lower the better strategy should be utilized very cautiously when it is applied to older patients and those with significant functional limitation such as dementia and parkinsonism.</s><s>Looser but reasonable targets may prevent the deterioration of cognitive function as well as reduce the incident dementia <ref type="bibr" target="#b14">(Huang &amp; Davis, 2015)</ref>.</s><s>Balance between the prevention of cardiovascular and cerebrovascular diseases and the preservation of cognitive functions deserves more attention when we are considering the target of control of each VRF associated with older patients.</s></p><p><s>Determination of the most suitable targets of control needs more evidence from further researches of the elderly.</s></p><p><s>The study has limitations that should be noted.</s><s>First, the sample size of PDD group in this study is relatively small.</s><s>Further researches should include a greater number of PDD patients for a better comparison.</s></p><p><s>Second, our research was conducted in only one hospital in central Taiwan.</s><s>Therefore, selection bias may arise, and our findings may not be generalizable to all patients with DLB, PDD, or AD.</s><s>Future studies should target recruitment of dementia patients from multiple centers in order to reduce the selection bias.</s><s>Third, the comparison of VRFs between DLB, PDD, and AD in our study was cross-sectional.</s><s>Therefore, causal relationship of VRFs and dementia is not able to be speculated.</s><s>Fourth, because of the lack of more determinative equipment or facilities, such as genetic study, dopamine transporter uptake imaging, amyloid plaque imaging, CSF biomarkers, or pathological studies, the diagnosis of DLB, PDD, and AD was based only on clinical criteria.</s><s>Therefore, diagnosis bias may arise.</s><s>Future studies should include longitudinal as well as pathological data in order to investigate the contribution of VRFs to LBD.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>bility.</s><s>REM sleep behavior disorder (RBD) was diagnosed when the minimal criteria for RBD in the International Classification of Sleep Disorders (ICSD)-2 were positive or atonia was accompanied by REM sleep during polysomnography (PSG) study (American Academy of Sleep Medicine, 2005).</s><s>Cognitive tests of all patients and the activities of daily living function assessments according to their main caregiver were performed by a trained neuropsychologist.</s><s>Dementia and subtype of dementia were made by a consensus meeting composed of three senile neurologists, one geriatric psychiatrist, and one neuropsychologist.</s><s>All patients received at least a cerebral CT or MRI, and most patients received a set of blood screening tests including complete blood count, COT, GPT, BUN, creatinine, total cholesterol, TG, ac glucose, and HbA1c.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>Chinese version of SPSS 19.0 for Windows (IBM, SPSS Inc., Chicago) was used for statistical analyses.</s><s>Comparisons between DLB, PDD, and AD groups on demographic data, neuropsychological tests, motor score of UPDRS, VHs subscale (frequency x severity) of NPI, the composite scores (frequency x severity) of NPI, and | 3 of 7 CHAN et Al.</s><s>measurements of VRFs were analyzed using one-way ANOVA with either the Bonferroni or Dunnett T3 post hoc analysis according to the homogeneity of variances.</s><s>Sex, CDR, clinical features, clinical history of VRFs, and current medications were analyzed with the chi-square test.</s><s>For the comparison of association of VRFs among patients with LBD and AD, we used a multivariable estimate model, and odds ratios (ORs) were adjusted for age, sex, smoking, systolic and diastolic blood pressures, fasting glucose, body mass index, triglyceride, and total cholesterol.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>show significantly higher systolic pressure (SBP; F = 14.390, p &lt; .001),</s><s>diastolic pressure (DBP; F = 3.173, p = .043),</s><s>waist (F = 8.791, p &lt; .001),</s><s>body mass index (BMI; F = 15.009,</s><s>p &lt; .001),</s><s>ac glucose (F = 3.514, p = .032),</s><s>and HbA1c (F = 8.167, p &lt; .001) in AD than other two groups.The comparisons of VRFs between LBD (combined DLB and PDD) and AD are summarized in Table4.</s><s>Multivariable ORs were adjusted for age, sex, smoking, systolic and diastolic blood pressures, fasting glucose, body mass index, triglyceride, and total cholesterol, and showed that SBP in the first tertile (80-128 mmHg; OR = 5.4), BMI in the first tertile (14.1-23.5;</s><s>OR = 3.1) and the second tertile(23.6-26.4;</s><s>OR = 4.0), and TG in the first tertile (23-90; OR = 17.9) were significantly higher in LBD than in AD.</s><s>Total cholesterol was lower in LBD in the first tertile (67-154; OR = 0.3) than AD.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head></head><label></label><figDesc><div><p><s><ref type="bibr" target="#b24">Papapetropoulos et al. on 2004 and</ref> 2006  studied the contribution of systemic or brain vascular diseases to the progression of PD and used very strict criteria to avoid the contamination of vascular parkinsonism, and their findings clearly suggested that the presence of vascular disease on idiopathic PD patients may aggravate PD severity(Papapetropoulos</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head></head><label></label><figDesc><div><p><s>T A B L E 2 Comparison of history of vascular risk factors (VRFs) and current medication among DLB, PDD, and AD groups</s></p></div></figDesc><table><row><cell></cell><cell>n (%)</cell><cell></cell><cell></cell><cell></cell><cell cols="2">Odds ratio (95% CI)</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>DLB</cell><cell></cell><cell>PDD</cell><cell>AD</cell><cell cols="2">DLB versus AD</cell><cell cols="2">PDD versus AD</cell><cell>PDD versus DLB</cell></row><row><cell>History</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Hypertension</cell><cell cols="2">33 (60.0)</cell><cell>16 (47.1)</cell><cell>51 (65.4)</cell><cell cols="2">0.79 (0.39-1.62)</cell><cell cols="2">0.47 (0.21-1.07)</cell><cell>0.59 (0.25-1.40)</cell></row><row><cell>Diabetes</cell><cell cols="2">16 (29.1)</cell><cell>6 (17.6)</cell><cell>24 (30.8)</cell><cell cols="2">0.92 (0.43-1.96)</cell><cell cols="2">0.48 (0.18-1.32)</cell><cell>0.52 (0.18-1.50)</cell></row><row><cell>Smoking</cell><cell cols="2">22 (40.0)</cell><cell>8 (25.8)</cell><cell>23 (29.5)</cell><cell cols="2">1.59 (0.77-3.90)</cell><cell cols="2">0.83 (0.33-2.13)</cell><cell>0.52 (0.20-1.37)</cell></row><row><cell>Physical inactivity</cell><cell cols="2">36 (65.5)</cell><cell>17 (54.8)</cell><cell>48 (61.5)</cell><cell cols="2">1.18 (0.58-2.43)</cell><cell cols="2">0.76 (0.33-1.76)</cell><cell>0.64 (0.26-1.58)</cell></row><row><cell>Hyperlipidemia</cell><cell cols="2">4 (7.3)</cell><cell>2 (5.9)</cell><cell>11 (14.1)</cell><cell cols="2">0.48 (0.14-1.59)</cell><cell cols="2">0.38 (0.08-1.82)</cell><cell>0.80 (0.14-4.60)</cell></row><row><cell>Atherosclerosis</cell><cell cols="2">2 (3.6)</cell><cell>2 (5.9)</cell><cell>9 (11.5)</cell><cell cols="2">0.29 (0.06-1.40)</cell><cell cols="2">0.48 (0.10-2.35)</cell><cell>1.25 (0.46-3.37)</cell></row><row><cell>Current medication</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Antihypertensive drugs</cell><cell cols="2">22 (40.0)</cell><cell>15 (44.1)</cell><cell>37 (47.4)</cell><cell cols="2">0.74 (0.37-1.49)</cell><cell cols="2">0.88 (0.39-1.97)</cell><cell>1.18 (0.50-1.81)</cell></row><row><cell>Antidiabetic drugs</cell><cell cols="2">11 (20.0)</cell><cell>3 (8.8)</cell><cell>21 (26.9)</cell><cell cols="2">0.68 (0.30-1.55)</cell><cell cols="2">0.26 (0.07-0.95)*</cell><cell>0.39 (0.10-1.50)</cell></row><row><cell>Statins</cell><cell cols="2">3 (5.5)</cell><cell>2 (5.9)</cell><cell>6 (7.7)</cell><cell cols="2">0.69 (0.17-2.90)</cell><cell cols="2">0.75 (0.14-3.92)</cell><cell>1.08 (0.17-6.84)</cell></row><row><cell>Antiplatelet drugs</cell><cell cols="2">16 (29.1)</cell><cell>7 (20.6)</cell><cell>17 (21.8)</cell><cell cols="2">1.47 (0.67-3.25)</cell><cell cols="2">0.93 (0.35-2.50)</cell><cell>0.63 (0.23-1.74)</cell></row><row><cell>Antiparkinson drugs</cell><cell cols="2">26 (47.3)</cell><cell>27 (79.4)</cell><cell>10 (12.8)</cell><cell>6.10</cell><cell></cell><cell>26.23</cell><cell></cell><cell>4.30 (1.61-11.53)**</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">(2.61-14.25)**</cell><cell cols="2">(9.05-75.99)**</cell><cell></cell></row><row><cell>Antidementia drugs</cell><cell cols="2">5 (9.1)</cell><cell>10 (29.4)</cell><cell>19 (24.4)</cell><cell cols="2">0.31 (0.11-0.89)*</cell><cell cols="2">1.29 (0.53-3.19)</cell><cell>4.17 (1.28-13.54)**</cell></row><row><cell cols="3">DLB (n = 55)</cell><cell>PDD (n = 34)</cell><cell></cell><cell>AD (n = 78)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Mean</cell><cell>SD</cell><cell>Mean</cell><cell>SD</cell><cell>Mean</cell><cell>SD</cell><cell>F</cell><cell>p</cell><cell>post hoc</cell></row><row><cell>Systolic BP, mmHg</cell><cell>130.4</cell><cell>16.9</cell><cell>131.8</cell><cell>24.4</cell><cell>143.1</cell><cell>19.7</cell><cell>7.914</cell><cell>.001</cell><cell>DLB = PDD; DLB &lt; AD;</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>PDD &lt; AD</cell></row><row><cell>Diastolic BP, mmHg</cell><cell>71.0</cell><cell>10.5</cell><cell>68.9</cell><cell>11.4</cell><cell>73.9</cell><cell>10.7</cell><cell>2.770</cell><cell>.066</cell><cell>DLB = PDD; DLB = AD;</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>PDD = AD</cell></row><row><cell>Heart rate, beats/min</cell><cell>75.3</cell><cell>14.2</cell><cell>74.7</cell><cell>16.6</cell><cell>76.5</cell><cell>14.4</cell><cell>0.206</cell><cell>.814</cell><cell>DLB = PDD; DLB = AD;</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>PDD = AD</cell></row><row><cell>BMI, kg/m 2</cell><cell>23.3</cell><cell>3.1</cell><cell>24.9</cell><cell>3.2</cell><cell>25.7</cell><cell>2.9</cell><cell>10.156</cell><cell>&lt;.001</cell><cell>DLB &lt; AD; DLB = PDD;</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>PDD = AD</cell></row><row><cell>Blood ac glucose,</cell><cell>116.4</cell><cell>40.0</cell><cell>101.2</cell><cell>52.6</cell><cell>125.7</cell><cell>44.0</cell><cell>3.400</cell><cell>.036</cell><cell>PDD &lt; AD; DLB = PDD;</cell></row><row><cell>mg/dl</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>DLB = AD</cell></row><row><cell>HbA1c</cell><cell>6.8</cell><cell>0.9</cell><cell>6.7</cell><cell>0.8</cell><cell>7.6</cell><cell>1.3</cell><cell>12.210</cell><cell>&lt;.001</cell><cell>DLB = PDD; DLB &lt; AD;</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>PDD &lt; AD</cell></row><row><cell>TG</cell><cell>93.4</cell><cell>27.3</cell><cell>101.2</cell><cell>52.6</cell><cell>139.3</cell><cell>55.1</cell><cell>17.369</cell><cell>&lt;.001</cell><cell>DLB = PDD; DLB &lt; AD;</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>PDD &lt; AD</cell></row><row><cell>Total cholesterol,</cell><cell>174.0</cell><cell>37.9</cell><cell>173.6</cell><cell>30.5</cell><cell>175.7</cell><cell>37.9</cell><cell>0.058</cell><cell>.944</cell><cell>DLB = PDD; DLB = AD;</cell></row><row><cell>mg/dl</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>PDD = AD</cell></row><row><cell>LDL-C, mg/dl</cell><cell>107.5</cell><cell>30.5</cell><cell>104.7</cell><cell>28.2</cell><cell>113.1</cell><cell>34.0</cell><cell>0.975</cell><cell>.380</cell><cell>DLB = PDD; DLB = AD;</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>PDD = AD</cell></row><row><cell cols="10">n, number of cases; DLB, dementia with Lewy bodies; PDD, Parkinson's disease dementia; AD, Alzheimer's disease; BP, blood pressure; BMI, body mass</cell></row><row><cell cols="8">index; HbA1c, glycated hemoglobin; LDL-C, low-density lipoprotein; HDL-C, high-density lipoprotein.</cell><cell></cell><cell></cell></row></table><note><p><s>n, Number of cases; DLB, dementia with Lewy bodies; PDD, Parkinson's disease dementia; AD, Alzheimer's disease.</s><s>*p &lt; .05. **p &lt; .005.</s><s>T A B L E 3 Comparison of measurement of vascular risk factors (VRFs) among DLB, PDD, and AD groups</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head></head><label></label><figDesc><div><p><s>T A B L E 4 Multivariable risk estimates (ORs) for LBD (DLB + PDD) patients compared to AD patients Multivariable ORs are derived from a stepwise procedure that considered age, sex, disease severity, antiparkinson drugs, systolic and diastolic blood pressures, glycated hemoglobin, body mass index, triglyceride, total cholesterol, and low-density lipoprotein.</s><s>c ORs absent for variables not included in multivariable regression analysis.</s></p></div></figDesc><table><row><cell></cell><cell>n (%)</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>AD (n = 78)</cell><cell>LBD (n = 89)</cell><cell>Crude OR a (95% CI)</cell><cell>Multivariable OR b (95%CI)</cell></row><row><cell>Antiparkinson drugs</cell><cell>10 (12.8)</cell><cell>53 (59.6)</cell><cell>10.01 (4.56-22.00) p &lt; .001</cell><cell>c</cell></row><row><cell>SBP, mmHg</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>1st tertile (87-128)</cell><cell>16 (20.5)</cell><cell>39 (43.8)</cell><cell>1</cell><cell>1</cell></row><row><cell>2nd tertile (129-143)</cell><cell>25 (31.1)</cell><cell>29 (32.6)</cell><cell>0.41 (0.13-1.27)</cell><cell>0.54 (0.20-1.45)</cell></row><row><cell>3rd tertile (144-198)</cell><cell>37 (47.4)</cell><cell>21 (23.6)</cell><cell>0.20 (0.06-0.71) p = 013</cell><cell>0.28 (0.10-0.76) p = .012</cell></row><row><cell>DBP, mmHg</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>1st tertile (48-66)</cell><cell>23 (23.8)</cell><cell>30 (33.7)</cell><cell>1</cell><cell>c</cell></row><row><cell>2nd tertile (67-76)</cell><cell>23 (38.9)</cell><cell>32 (36.0)</cell><cell>2.21 (0.67-7.30)</cell><cell>c</cell></row><row><cell>3rd tertile (77-98)</cell><cell>32 (37.3)</cell><cell>27 (30.3)</cell><cell>1.83 (0.54-6.22)</cell><cell>c</cell></row><row><cell>Fasting glucose, mg/dl</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>1st tertile (69-102)</cell><cell>20 (25.6)</cell><cell>34 (38.2)</cell><cell>1</cell><cell>c</cell></row><row><cell>2nd tertile (103-118)</cell><cell>22 (28.2)</cell><cell>34 (38.2)</cell><cell>1.57 (0.52-4.70)</cell><cell>c</cell></row><row><cell>3rd tertile (119-349)</cell><cell>36 (46.2)</cell><cell>21 (23.6)</cell><cell>0.64 (0.19-2.11)</cell><cell>c</cell></row><row><cell>HbA1c, mmol/mol</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>1st tertile (4.2-6.7)</cell><cell>17 (21.8)</cell><cell>40 (44.9)</cell><cell>1</cell><cell>1</cell></row><row><cell>2nd tertile (6.8-7.2)</cell><cell>17 (21.8)</cell><cell>39 (43.8)</cell><cell>0.68 (0.24-1.95)</cell><cell>0.72 (0.28-1.84)</cell></row><row><cell>3rd tertile (7.3-11.6)</cell><cell>44 (56.4)</cell><cell>10 (11.2)</cell><cell>0.19 (0.06-0.65) p = .008</cell><cell>0.15 (0.05-0.41) p &lt; .001</cell></row><row><cell>BMI, kg/m 2</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>1st tertile (15.6-23.5)</cell><cell>13 (16.7)</cell><cell>43 (48.3)</cell><cell>1</cell><cell>1</cell></row><row><cell>2nd tertile (23.6-26.4)</cell><cell>32 (41.0)</cell><cell>24 (27.0)</cell><cell>0.20 (0.06-0.62) p = .006</cell><cell>0.29 (0.11-0.76) p = .012</cell></row><row><cell>3rd tertile (26.5-32.2)</cell><cell>33 (42.3)</cell><cell>22 (24.7)</cell><cell>0.34 (0.11-1.06)</cell><cell>0.42 (0.15-1.16)</cell></row><row><cell>TG, mg/dl</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>1st tertile (23-90)</cell><cell>13 (16.7)</cell><cell>41 (46.7)</cell><cell>1</cell><cell>1</cell></row><row><cell>2nd tertile (91-126)</cell><cell>21 (26.9)</cell><cell>38 (42.1)</cell><cell>0.63 (0.22-1.82)</cell><cell>0.62 (0.25-1.58)</cell></row><row><cell>3rd tertile (127-310)</cell><cell>44 (56.4)</cell><cell>10 (11.2)</cell><cell>0.08 (0.02-0.30) p &lt; .001</cell><cell>0.13 (0.04-0.36) p &lt; .001</cell></row><row><cell>Total cholesterol, mg/dl</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>1st tertile (104-154)</cell><cell>27 (34.6)</cell><cell>26 (29.2)</cell><cell>1</cell><cell>c</cell></row><row><cell>2nd tertile (155-189)</cell><cell>28 (35.9)</cell><cell>34 (38.2)</cell><cell>2.47 (0.71-8.63)</cell><cell>c</cell></row><row><cell>3rd tertile (191-282)</cell><cell>23 (29.5)</cell><cell>29 (32.6)</cell><cell>13.64 (2.10-88.71) p = .006</cell><cell>c</cell></row><row><cell>LDL, mg/dl</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>1st tertile (37-95)</cell><cell>26 (33.3)</cell><cell>29 (32.6)</cell><cell>1</cell><cell>c</cell></row><row><cell>2nd tertile (96-121)</cell><cell>24 (30.8)</cell><cell>35 (35.8)</cell><cell>0.76 (0.21-2.75)</cell><cell>c</cell></row><row><cell>3rd tertile (122-203)</cell><cell>28 (35.9)</cell><cell>25 (28.1)</cell><cell>0.20 (0.01-1.18)</cell><cell>c</cell></row><row><cell cols="5">n, number of cases; AD, Alzheimer's disease; LBD, Lewy body dementia; DLB, dementia with Lewy bodies; PDD, Parkinson's disease dementia; HbA1c,</cell></row><row><cell cols="4">glycated hemoglobin; BMI, body mass index; TG, triglyceride; LDL, low-density lipoprotein.</cell><cell></cell></row><row><cell cols="2">a Crude ORs are adjusted for age and sex.</cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>b</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head></head><label></label><figDesc><div><p><s>(Rektor et al., 2009)awek et al., , 2010)).Schelp et al. studiedthe relationship between metabolic disorders and progression of dementia in PD and revealed that dementia in PD is age-dependent and not related to disease duration(Schelp et al., 2012).Rektor et al. on 2009 studied the impact of brain vascular pathology on the clinical status of PD and found subclinical vascular pathology could influence the clinical status by contributing to motor and cognitive dysfunction in PD(Rektor et al., 2009).</s></p></div></figDesc><table><row><cell>. A prospective study of Parkinson's disease</cell></row><row><cell>risk by Simon et al. on 2007 revealed no significantly relationship to</cell></row><row><cell>history of hypertension, hypercholesterolemia, or diabetes, and the risk</cell></row><row><cell>may modestly decline with increasing blood cholesterol levels (Simon</cell></row><row><cell>et al., Haugarvoll et al. studied a large and representative cohort</cell></row><row><cell>of patients with PD and found cerebrovascular risk factors were not as-</cell></row><row><cell>sociated with incident dementia (Haugarvoll et al., 2005). Sławek et al.</cell></row><row><cell>on 2008 studied VRFs and white matter vascular abnormalities and re-</cell></row><row><cell>vealed no significant contribution to cognitive impairment in patients</cell></row><row><cell>with PD (</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENT</head><p><s>We would like to thank Professor Tsung-Lin Cheng in National Changhua University of Education for his discussion and suggestion during the experiment design and statistical analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AUTHOR'S CONTRIBUTION</head><p><s>P.C. Chan undertook the literature searches and the data analyses, edited all author contributions, and was mainly responsible for drafts of the manuscript.</s><s>P.Y.</s><s>Chiu undertook the data analyses and was responsible for revisions and drafts of the manuscript.</s><s>C.Y. Wei participated in data analysis and contributed to revisions of the manuscript.</s><s>G.U. Huang participated in data analysis and contributed to revisions of the manuscript.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONFLICT OF INTEREST</head><p><s>None declared.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ORCID</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Pai-Yi Chiu</head><p><s>http://orcid.org/0000-0003-2552-4516</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">International classification of sleep disorder</title>
		<imprint>
			<date type="published" when="2005">2005</date>
			<publisher>American Academy of Sleep Medicine</publisher>
			<pubPlace>Westchester, IL</pubPlace>
		</imprint>
	</monogr>
	<note>Diagnostic and coding manual</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies</title>
		<author>
			<persName><forename type="first">C</forename><surname>Ballard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mckeith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Burn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Harrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>O'brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lowery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ince</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neurologica Scandinavica</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="366" to="371" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">Increased risk of Alzheimer&apos;s disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Biessels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Kappelle</surname></persName>
		</author>
		<idno type="DOI">10.1042/BST0331041</idno>
		<ptr target="https://doi.org/10.1042/BST0331041" />
		<imprint>
			<date type="published" when="2005">2005</date>
			<publisher>Biochemical Society Transactions</publisher>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="1041" to="1044" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Risk factors for dementia with Lewy bodies: A case-control study</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Boot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Orr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Ahlskog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Ferman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">S</forename><surname>Pankratz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Knopman</surname></persName>
		</author>
		<idno type="DOI">10.1212/WNL.0b013e3182a2cbd1</idno>
		<ptr target="https://doi.org/10.1212/WNL.0b013e3182a2cbd1" />
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="833" to="840" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Frequency of early and late-onset dementias in a Taiwanese dementia clinic: First the Lin-Shin Dementia registry project</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">Y</forename><surname>Chiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">L</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Lai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Taiwanese Journal of Psychiatry</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="29" to="39" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Cummings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mega</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rosenberg-Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Carusi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gornbein</surname></persName>
		</author>
		<idno type="DOI">10.1212/WNL.44.12.2308</idno>
		<ptr target="https://doi.org/10.1212/WNL.44.12.2308" />
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="2308" to="2314" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Clinical diagnostic criteria for dementia associated with Parkinson&apos;s disease</title>
		<author>
			<persName><forename type="first">M</forename><surname>Emre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Aarsland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Burn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Duyckaerts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Mizuno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Goldman</surname></persName>
		</author>
		<idno type="DOI">10.1002/(ISSN)1531-8257</idno>
		<ptr target="https://doi.org/10.1002/" />
	</analytic>
	<monogr>
		<title level="j">Movement Disorders</title>
		<idno type="ISSN">)1531-8257</idno>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1689" to="1707" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">DLB fluctuations specific features that reliably differentiate DLB from AD and normal aging</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Ferman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Boeve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Ivnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Knopman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Dickson</surname></persName>
		</author>
		<idno type="DOI">10.1212/WNL.62.2.181</idno>
		<ptr target="https://doi.org/10.1212/WNL.62.2.181" />
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="181" to="187" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Midlife and late-life obesity and the risk of dementia: Cardiovascular health study</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Fitzpatrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Kuller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">L</forename><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Diehr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>O'meara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Longstreth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Luchsinger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Archives of Neurology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="336" to="342" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">A practical method for grading the cognitive state of patients for the clinician</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Folstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Folstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Mchugh</surname></persName>
		</author>
		<idno type="DOI">10.1016/0022-3956(75)90026-6</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Psychiatric Research</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="189" to="198" />
			<date type="published" when="1975">1975</date>
		</imprint>
	</monogr>
	<note>Mini-mental state</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">The prevention of dementia with antihypertensive treatment: New evidence from the Systolic Hypertension in Europe (Syst-Eur) study</title>
		<author>
			<persName><forename type="first">F</forename><surname>Forette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Seux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Staessen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Thijs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Babarskiene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Babeanu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Kobalava</surname></persName>
		</author>
		<idno type="DOI">10.1001/archinte.162.18.2046</idno>
		<ptr target="https://doi.org/10.1001/archinte.162.18.2046" />
	</analytic>
	<monogr>
		<title level="j">Archives of Internal Medicine</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="page" from="2046" to="2052" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Risk factors for vascular dementia and Alzheimer disease</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Gorelick</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.STR.0000143318.70292.47</idno>
		<ptr target="https://doi.org/10.1161/01.STR.0000143318.70292.47" />
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2620" to="2622" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note>Suppl 1</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies</title>
		<author>
			<persName><forename type="first">K</forename><surname>Gudala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bansal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Schifano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bhansali</surname></persName>
		</author>
		<idno type="DOI">10.1111/jdi.12087</idno>
		<ptr target="https://doi.org/10.1111/jdi.12087" />
	</analytic>
	<monogr>
		<title level="j">Journal of Diabetes Investigation</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="640" to="650" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson&apos;s disease</title>
		<author>
			<persName><forename type="first">K</forename><surname>Haugarvoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Aarsland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wentzel-Larsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Larsen</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1600-0404.2005.00389.x</idno>
		<ptr target="https://doi.org/10.1111/j.1600-0404.2005.00389.x" />
	</analytic>
	<monogr>
		<title level="j">Acta Neurologica Scandinavica</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="386" to="390" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Glycemic control in older adults with diabetes mellitus</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Davis</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2015.8345</idno>
		<ptr target="https://doi.org/10.1001/jama.2015.8345" />
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">314</biblScope>
			<biblScope unit="page" from="1509" to="1510" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Update on Dementia with Lewy bodies</title>
		<author>
			<persName><forename type="first">S</forename><surname>Karantzoulis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Galvin</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13670-013-0053-6</idno>
		<ptr target="https://doi.org/10.1007/s13670-013-0053-6" />
	</analytic>
	<monogr>
		<title level="j">Current Translational Geriatrics and Experimental Gerontology Reports</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="196" to="204" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kivipelto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ngandu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fratiglioni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Viitanen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kåreholt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Winblad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nissinen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Archives of Neurology</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="1556" to="1560" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Midlife blood pressure and dementia: The Honolulu-Asia aging study</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Launer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Ross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Petrovitch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Masaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Foley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Havlik</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0197-4580(00)00096-8</idno>
	</analytic>
	<monogr>
		<title level="j">Neurobiology of Aging</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="49" to="55" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Aggregation of vascular risk factors and risk of incident Alzheimer disease</title>
		<author>
			<persName><forename type="first">J</forename><surname>Luchsinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Reitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Honig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">X</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mayeux</surname></persName>
		</author>
		<idno type="DOI">10.1212/01.wnl.0000172914.08967.dc</idno>
		<ptr target="https://doi.org/10.1212/01.wnl.0000172914.08967.dc" />
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="545" to="551" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Diabetes mellitus and risk of Alzheimer&apos;s disease and dementia with stroke in a multiethnic cohort</title>
		<author>
			<persName><forename type="first">J</forename><surname>Luchsinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">X</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Stern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mayeux</surname></persName>
		</author>
		<idno type="DOI">10.1093/aje/154.7.635</idno>
		<ptr target="https://doi.org/10.1093/aje/154.7.635" />
	</analytic>
	<monogr>
		<title level="j">American Journal of Epidemiology</title>
		<imprint>
			<biblScope unit="volume">154</biblScope>
			<biblScope unit="page" from="635" to="641" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">G</forename><surname>Mckeith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Dickson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Emre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>O'brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Feldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Aarsland</surname></persName>
		</author>
		<idno type="DOI">10.1212/01.wnl.0000187889.17253.b1</idno>
		<ptr target="https://doi.org/10.1212/01.wnl.0000187889.17253.b1" />
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="1863" to="1872" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">G</forename><surname>Mckeith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Galasko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kosaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Dickson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Hansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lennox</surname></persName>
		</author>
		<idno type="DOI">10.1212/WNL.47.5.1113</idno>
		<ptr target="https://doi.org/10.1212/WNL.47.5.1113" />
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="1113" to="1124" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Clinical diagnosis of Alzheimer&apos;s disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">G</forename><surname>Mckhann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Drachman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Folstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Katzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Stadlan</surname></persName>
		</author>
		<idno type="DOI">10.1212/WNL.34.7.939</idno>
		<ptr target="https://doi.org/10.1212/WNL.34.7.939" />
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="939" to="944" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">The clinical dementia rating (CDR): Current version and scoring rules</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<idno type="DOI">10.1212/WNL.43.11.2412-a</idno>
		<ptr target="https://doi.org/10.1212/WNL.43.11.2412-a" />
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="2412" to="2414" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">The effect of vascular disease on late onset Parkinson&apos;s disease</title>
		<author>
			<persName><forename type="first">S</forename><surname>Papapetropoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ellul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Argyriou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Talelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Chroni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Papapetropoulos</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1468-1331.2003.00748.x</idno>
		<ptr target="https://doi.org/10.1046/j.1468-1331.2003.00748.x" />
	</analytic>
	<monogr>
		<title level="j">European Journal of Neurology</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="231" to="235" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Is ischemic cerebrovascular disease a risk factor for dementia in patients with Parkinson&apos;s disease?</title>
		<author>
			<persName><forename type="first">S</forename><surname>Papapetropoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Villar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Mash</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neurologica Scandinavica</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="353" to="354" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">A summary risk score for the prediction of Alzheimer disease in elderly persons</title>
		<author>
			<persName><forename type="first">C</forename><surname>Reitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">X</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Schupf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Manly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mayeux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Luchsinger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Archives of Neurology</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="835" to="841" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Vascular pathology in patients with idiopathic Parkinson&apos;s Disease</title>
		<author>
			<persName><forename type="first">I</forename><surname>Rektor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Goldemund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sheardová</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Rektorová</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Michálková</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dufek</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.parkreldis.2008.02.007</idno>
		<ptr target="https://doi.org/10.1016/j.parkreldis.2008.02.007" />
	</analytic>
	<monogr>
		<title level="j">Parkinsonism &amp; Related Disorders</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="24" to="29" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Metabolic syndrome and dementia associated with Parkinson&apos;s disease: Impact of age and hypertension</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">O</forename><surname>Schelp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Mendes-Chiloff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bazan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">C</forename><surname>Paduan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Pioltini</surname></persName>
		</author>
		<idno type="DOI">10.1590/S0004-282X2012000200008</idno>
		<ptr target="https://doi.org/10.1590/S0004-282X2012000200008" />
	</analytic>
	<monogr>
		<title level="j">Arquivos de Neuro-Psiquiatria</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="114" to="118" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Reduced risk factors for vascular disorders in Parkinson disease patients: A case-control study</title>
		<author>
			<persName><forename type="first">G</forename><surname>Scigliano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Musicco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Soliveri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Piccolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ronchetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Girotti</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.STR.0000217384.03237.9c</idno>
		<ptr target="https://doi.org/10.1161/01.STR.0000217384.03237.9c" />
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="1184" to="1188" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Simon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schwarzschild</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ascherio</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title/>
		<author>
			<persName><surname>Hypertension</surname></persName>
		</author>
		<author>
			<persName><surname>Risk Of Parkinson Disease</surname></persName>
		</author>
		<idno type="DOI">10.1212/01.wnl.0000271883.45010.8a</idno>
		<ptr target="https://doi.org/10.1212/01.wnl.0000271883.45010.8a" />
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="1688" to="1695" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The influence of vascular risk factors and white matter hyperintensities on the degree of cognitive impairment in Parkinson&apos;s disease</title>
		<author>
			<persName><forename type="first">J</forename><surname>Sławek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wieczorek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Derejko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dubaniewicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Brockhuis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sitek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lass</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurologia i Neurochirurgia Polska</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="505" to="512" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Vascular risk factors do not contribute to motor and cognitive impairment in Parkinson&apos;s disease</title>
		<author>
			<persName><forename type="first">J</forename><surname>Sławek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wieczorek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Derejko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dubaniewicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Brockhuis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sitek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lass</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Parkinsonism &amp; Related Disorders</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="73" to="74" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">The cognitive abilities screening instrument (CASI): A practical test for cross-cultural epidemiological studies of dementia</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Teng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hasegawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Homma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Imai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Larson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Graves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>White</surname></persName>
		</author>
		<idno type="DOI">10.1017/S1041610294001602</idno>
		<ptr target="https://doi.org/10.1017/S1041610294001602" />
	</analytic>
	<monogr>
		<title level="j">International Psychogeriatrics</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="45" to="58" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer&apos;s Coordinating Centre</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Toledo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Arnold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Raible</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Brettschneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">X</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Grossman</surname></persName>
		</author>
		<author>
			<persName><surname>Trojanowski</surname></persName>
		</author>
		<idno type="DOI">10.1093/brain/awt188</idno>
		<ptr target="https://doi.org/10.1093/brain/awt188" />
	</analytic>
	<monogr>
		<title level="j">J. Q</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="2697" to="2706" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Brain. Pt 9</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
